GlassScriptPhysician profile
Santosh S Nandi
NPI 1851489991
$7,228.78
in general payments reported to CMS, 2019-2025
33 companies · $2,534 in 2025
The $2,534 reported for 2025 was more than what 83% of Colon & Rectal Surgery providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $409 · 2020: $1,295 · 2021: $1,069 · 2022: $454 · 2023: $820 · 2024: $648 · 2025: $2,534.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,250 · Food and Beverage: $1,408 · Gift: $325 · Education: $18.09.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,250.00 |
| Food and Beverage | $1,408.34 |
| Gift | $325.12 |
| Education | $18.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Conmed Corporation | $2,299.15 | 2023-2025 | Airseal |
| Braintree Laboratories, INC. | $962.97 | 2019-2025 | Sutab, Suflave |
| Covidien LP | $813.78 | 2019-2020 | |
| Medtronic, INC. | $804.43 | 2021-2022 | |
| Intuitive Surgical, INC. | $507.74 | 2019-2024 | Da Vinci Surgical System |
| Davol INC. | $233.57 | 2019-2023 | Phasix Mesh |
| Baudax Bio INC. | $227.45 | 2020-2021 | |
| Tela Bio, INC. | $164.39 | 2024 | Ovitex 2s |
| Mimedx Group, INC. | $150.03 | 2025 | |
| Aroa Biosurgery Incorporated | $119.88 | 2022 | |
| Axonics, INC. | $110.55 | 2021-2024 | Bulkamid, Axonics |
| Merck Sharp & Dohme LLC | $108.47 | 2019-2024 | Bridion |
| Ferring Pharmaceuticals INC. | $76.21 | 2019-2020 | |
| Stryker Corporation | $72.12 | 2023-2024 | Spy-Phi System, Pneumosure |
| Convatec INC. | $71.70 | 2020-2023 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $71.14 | 2019-2021 | |
| Boston Scientific Corporation | $53.65 | 2025 | Axonics |
| Myriad Genetic Laboratories, INC. | $43.09 | 2024 | Myrisk |
| Shire North American Group INC | $37.23 | 2019 | |
| Olympus America INC. | $35.91 | 2019 | |
| Acell, INC. | $34.15 | 2019 | |
| Trevena, INC. | $30.23 | 2022 | |
| Coopersurgical, INC. | $25.78 | 2021 | |
| Heron Therapeutics, INC. | $23.21 | 2022 | |
| Integra Lifesciences Corporation | $20.42 | 2025 | Integra, Omnigraft, Integra Dermal Regeneration Template |
| Edwards Lifesciences Corporation | $19.89 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $19.84 | 2023 | Gattex |
| Cook Medical LLC | $18.00 | 2019 | |
| Alfasigma USA, INC. | $17.84 | 2020 | |
| Dilon Technologies, INC. | $17.13 | 2024 | Hemoblast Bellows |
| Pacira Pharmaceuticals Incorporated | $15.27 | 2021 | |
| Acelrx Pharmaceuticals, INC. | $12.25 | 2020 | |
| Mallinckrodt Hospital Products INC. | $11.31 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Santosh Nandi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.